Dr. Elias Zerhouni, the first radiologist to serve as director of the National Institutes of Health, envisions a central role for medical imaging in 21st century medical research and practice. He predicted growth for image-guided therapies, imaging genomics, computer-based radiology applications, and molecular imaging during a lecture at the 2006 International Society for Magnetic Resonance in Medicine meeting in Seattle.
Dr. Elias Zerhouni, the first radiologist to serve as director of the National Institutes of Health, envisions a central role for medical imaging in 21st century medical research and practice. He predicted growth for image-guided therapies, imaging genomics, computer-based radiology applications, and molecular imaging during a lecture at the 2006 International Society for Magnetic Resonance in Medicine meeting in Seattle.
Breakthroughs that have transformed medicine rely on discoveries made at the juncture of scientific disciplines, he said. The application of computers to imaging revolutionized radiology. Real-time cine pushed cardiac imaging forward, and television adopted for x-ray technology led to interventional radiology. Imaging is no longer simply a method for creating images, but a method of extracting information for all physical scales from single molecules to the full organ.
"Today, biology is again driving new research, be it genomics or proteomics or targeted agents," Zerhouni said. "In this century, we will have to intervene before the damage is done. We need to preserve normal function, and our ability to detect patients at risk is increasing remarkably."
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.